Latest Regulatory Approvals News

Jade Gas Holdings has completed its appraisal program at the Tavan Tolgoi coal bed methane project, preparing to lodge its maiden gas reserve booking and advance development plans backed by fresh capital.

Australian Strategic Materials reports a 70% surge in NdFeB alloy production, installs pilot heavy rare earth furnace, and progresses its acquisition by Energy Fuels with regulatory approvals underway.

Meteoric Resources has reported strong pilot plant performance and advanced feasibility work at its Caldeira rare earths project, alongside a $50 million non-binding financing letter from Export Finance Australia and robust Brazilian government backing.

Premier1 Lithium completed its maiden RC drilling at Yalgoo and confirmed expanded gold anomalies at Rochefort through advanced geophysical surveys, setting up follow-up drilling in 2026.

Chalice Mining has bolstered its leadership and financing strategy while advancing a Feasibility Study for its Gonneville palladium-nickel-copper project, amid improving market conditions and promising exploration results.

CurveBeam AI reported stable device orders but faces regulatory delays for FDA and China clearances, while securing a A$4 million investment from WEGO Orthopaedics and advancing clinical collaborations with robotic surgery systems.

European Metals Holdings has secured critical regulatory milestones for its Cinovec Lithium Project, submitting the full Environmental Impact Assessment and obtaining Regional Rezoning approval. The company also raised A$3.46 million to support ongoing development.

Condor Energy has advanced its offshore Peru exploration with a new Raya West prospect, lifting its unrisked prospective resources above 3.3 billion barrels, while moving to 100% ownership of TEA 86 to streamline licence conversion and partnerships.

Conrad Asia Energy has taken a decisive step from exploration to production with the Final Investment Decision on its Mako Gas Project, booking reserves for the first time and progressing a major farm-down transaction.

Neurotech International has opened its first Phase 3 clinical site for NTI164 targeting Autism Spectrum Disorder, reported positive 90-day toxicology results, and launched a new Rett syndrome research collaboration.

Cleo Diagnostics (ASX:COV) has hit a major milestone by completing sample collection for its pivotal U.S. ovarian cancer trial, while progressing manufacturing and analytical validation steps toward FDA 510(k) submission.

Neometals Ltd has launched a 1-for-6 entitlement offer at A$0.04 per share alongside a two-tranche placement, targeting a combined A$13 million to advance gold and critical minerals projects.